ArticleJACS Au2026
Inductive Diastereoselective Rationale for a Catalytic Strategy to Build Densely Chiral Five-Membered Carbocycles.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a streamlined synthetic strategy for accessing stereocongested five-membered carbocycles from enantioenriched branched borylated 1,4-dienes. The method enables precise control over diastereoselectivity and enantiospecificity in the construction of adjacent stereocenters within the newly formed cyclic frameworks. DFT calculations provide an understanding of the origin of diastereoselection along the Cu-catalyzed borylcupration step, allowing one to establish a stereochemical model that rationalizes the key ligand-substrate and intrasubstrate interactions governing selectivity. Moreover, the resulting stereocongested cyclopentenes can be further elaborated through stereoselective alkene activation, enabling the installation of up to four contiguous stereocenters and granting access to architecturally complex, multistereogenic cyclopentane frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.